BHC Event
Watch the recording on our Nordic Webinar on Complement targeted therapy
C3-Targeted Therapy in C3G and Primary IC-MPGN
Program:
Moderator: Professor Stefan Jacobson, Department of Nephrology, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Welcome and introduction, by Stefan Jacobson
A deeper dive into the VALIANT phase 3 study data
Professor in Nephrology, Fadi Fakhouri, Head of Nephrology and Hypertension, Lausanne University Hospital “CHUV”, Switzerland (digital)
Where Does Complement Inhibition Fit Within the Treatment Paradigm for C3G, Primary IC-MPGN, ANCA-Associated Vasculitis and igAN?
Professor in Nephrology, Annette Bruchfeld, FERA, Senior Physician Linköping University
A caregiver perspective, and a multi-disciplinary approach to evidence generation
Founder, Marianne Silskjær Nielsen, CompCure